Related Experiment Video
Updated: Feb 19, 2026
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic
Roman N Rodionov1, Annett Heinrich2, Silke Brilloff1
1University Center for Vascular Medicine, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.
Insights
Lowering asymmetric dimethylarginine (ADMA) by overexpressing dimethylarginine dimethylaminohydrolase 1 (DDAH1) did not prevent diabetic nephropathy in mice. This suggests ADMA is not a primary driver of early diabetic kidney disease.
Area of Science:
- Cardiovascular disease research
- Nephrology
- Endocrinology
Background:
- Cardiovascular disease is a leading cause of death globally.
- Diabetic nephropathy significantly elevates cardiovascular risk.
- Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, is implicated in diabetic nephropathy pathogenesis.
Purpose of the Study:
- To investigate if overexpressing dimethylarginine dimethylaminohydrolase 1 (DDAH1) reduces ADMA levels and protects against diabetic nephropathy.
- To test the hypothesis that lowering ADMA ameliorates diabetic kidney disease progression.
Main Methods:
- Diabetes was induced using streptozotocin (STZ) in wild-type and DDAH1 transgenic mice.
- Plasma ADMA, creatinine, and albumin levels were measured.
- Kidney tissues were analyzed for markers of glomerular damage, inflammation, and proliferation.
Main Results:
- STZ successfully induced diabetes in all tested mice.
- DDAH1 overexpression reduced plasma ADMA in healthy mice but not significantly in diabetic mice.
- Diabetic mice, regardless of genotype, exhibited albuminuria, indicating kidney damage.
- No significant differences were observed in glomerular matrix expansion, podocyte injury, or inflammation between genotypes.
Conclusions:
- STZ-induced diabetes leads to early signs of nephropathy.
- Overexpression of DDAH1 and subsequent reduction in ADMA did not prevent these early diabetic nephropathy changes.
- ADMA is unlikely to be the primary mediator of early diabetic kidney disease in this model.
Background And Aims:
Cardiovascular disease is the major cause of morbidity and mortality in the world. Diabetes and its complications, such as diabetic nephropathy, dramatically increase cardiovascular risk. Association studies suggest that asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthases, plays a role in the pathogenesis of diabetic nephropathy. The major pathway of ADMA catabolism is hydrolysis by dimethylarginine dimethylaminohydrolase 1 (DDAH1). The goal of this study was to test the hypothesis that lowering ADMA by overexpression of DDAH1 protects from development of diabetic nephropathy.
Methods:
Diabetes was induced with streptozotocin (STZ) in wild type and DDAH1 transgenic mice. Healthy mice served as controls. Mice were sacrificed after 20 weeks of diabetes. ADMA levels were assessed by isotope-dilution tandem mass spectrometry, creatinine by standard laboratory methods and albumin by ELISA. Kidney tissues were stained for markers of glomerular cells, cell matrix, inflammation and cell proliferation.
Results:
STZ led to development of diabetes in all injected mice. Transgenic overexpression of DDAH1 led to a decrease in plasma ADMA levels in healthy animals. Diabetic state itself did not lead to elevation of plasma ADMA levels. Diabetic mice of both genotypes developed albuminuria (27 and 25 vs. 9 and 6 μg albumin/mg creatinine) (p < 0.01). There were no changes in glomerular matrix expansion, podocyte injury, inflammatory or proliferative response.
Conclusions:
STZ-induced diabetes led to the development of early features of diabetic nephropathy. Overexpression of DDAH1 and lowering of systemic ADMA levels did not prevent these changes, indicating that ADMA is not the major mediator of the early diabetic changes reflected by this experimental model.
More Related Videos
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
